CTRI/2014/05/004640已完成未知
EVALUATION OF CLINICAL OUTCOME OF THE VISIAN IMPLANTABLE COLLAMER LENS WITH CENTRAL FLOW TECHNOLOGY (V4C ICL) IN MYOPIA
ETRADHAMA SUPERSPECIALITY EYE HOSPITAl0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Myopia in the range (from0.50 diopter [D] to 18.00 D),
- •2.Age older than 20 years,
- •3.Corrected distance visual acuity (CDVA) of 20/40 or better,
- •4.Stable refraction,
- •5. Clear central cornea.
排除标准
- •1.Previous corneal refractive surgery,
- •2.Anterior chamber depth (acd) from the endothe-lium of less than 2.8 mm,
- •3. corneal endothelial cell density less than 2000 cell/mm2
- •4.Mesopic pupil larger than 7.0 mm,
- •5.history of glaucoma or ocular inï¬?ammation, pre-existing corneal disease,
- •6.endothelial count less than 2500 cells/mm
- •7. Cataract, history of glaucoma, amblyopia, retinal detachment ,diabetic retinopathy, macular degeneration, neuro-ophthalmic disease, and a history of ocular inflammation.
研究者
相似试验
尚未招募
2 期
Role of the viddha karma (Puncturing by neddle no 20) n the treatment of Manya stambha with the special reference to cervical spondylosisCTRI/2020/07/026383Parul Institute of Ayurved
尚未招募
2 期
A clinical trial to study the effect of Vidaryadi Modaka in patients with karshya[underweight childern]CTRI/2020/12/029796Dean Faculty of Ayurved Parul University
进行中（未招募）
不适用
Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration - IVB JSAEUCTR2006-003170-99-ITIVERSITA DEGLI STUDI DI UDINE
已完成
2 期
A phase II study evaluating abscopal effect of nivolumab in combination with local radiotherapy in patients with pretreated metastatic non-small cell lung cancerJPRN-UMIN000023838Department of Respiratory, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine17
进行中（未招募）
不适用
Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - NDMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060EUCTR2006-002351-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA